Ultragenyx Pharmaceutical | RARE - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
BioCryst Pharmaceuticals USD -553.84M 434.69M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Esperion Therapeutics USD -307.93M 5.97M 2026-03
Immunic USD 151.23M 157.91M 2026-03
Insmed USD 704.85M 34.12M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Kyowa Hakko Kirin JPY 892.74B 591M 2026-03
MacroGenics USD 21.2M 34.39M 2026-03
Moderna USD 7.41B 1.24B 2026-03
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
PTC Therapeutics USD -180.46M 24.85M 2026-03
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03
Xoma USD 87.94M 15.5M 2025-09